Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

uniQure N.V.

QURE · Nasdaq · CIK 0001590560 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

60 Form 4 transaction lines observed in the same window
38 sales · 22 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Kapusta Matthew CCEO, Managing Director
○▼○▼○▼○▼○▼
Kaye JackDirector
○▼○▼○▼○▼
Balachandran MadhavanDirector
○▼○▼○▼
Abi-Saab WalidChief Medical Officer
○▼▼○▼
Springhorn Jeremy P.Director
○▼
POST LEONARD EDirector
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
57Sales
33Other Form 4 lines
35SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING38 sale line(s) · context only
OTHER22 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
8,715,837
Previous report
9,920,512
Avg daily volume
4,488,701
Days to cover
1.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

90 transaction lines in the latest 365-day window; 465 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-02Kapusta Matthew CSale (S)Ordinary Shares21,082USD 45.16USD 952,051SEC filing ↗
2026-07-02Kapusta Matthew COption exercise / conversion (M)Ordinary Shares21,082USD 19.39USD 408,780SEC filing ↗
2026-06-30Kaye JackSale (S)Ordinary Shares21,167USD 46.44USD 983,030SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-02Kapusta Matthew CSale (S)Ordinary Shares21,082USD 45.16USD 952,051SEC filing ↗
2026-07-02Kapusta Matthew COption exercise / conversion (M)Ordinary Shares21,082USD 19.39USD 408,780SEC filing ↗
2026-06-30Kaye JackSale (S)Ordinary Shares21,167USD 46.44USD 983,030SEC filing ↗
2026-06-30Kaye JackOption exercise / conversion (M)Ordinary Shares21,167USD 23.44USD 496,230SEC filing ↗
2026-06-30Abi-Saab WalidSale (S)Ordinary Shares30,000USD 46.42USD 1,392,600SEC filing ↗
2026-06-30Abi-Saab WalidOption exercise / conversion (M)Ordinary Shares10,000USD 5.59USD 55,900SEC filing ↗
2026-06-26Abi-Saab WalidSale (S)Ordinary Shares1,434USD 46.86USD 67,197SEC filing ↗
2026-06-25Kapusta Matthew CSale (S)Ordinary Shares28,716USD 50.02USD 1,436,374SEC filing ↗
2026-06-25Kapusta Matthew COption exercise / conversion (M)Ordinary Shares28,716USD 31.71USD 910,584SEC filing ↗
2026-06-24Kapusta Matthew CSale (S)Ordinary Shares6,696USD 50.00USD 334,800SEC filing ↗
2026-06-24Kapusta Matthew COption exercise / conversion (M)Ordinary Shares4,128USD 31.71USD 130,899SEC filing ↗
2026-06-18Kapusta Matthew CSale (S)Ordinary Shares41,671USD 50.00USD 2,083,550SEC filing ↗
2026-06-18Kapusta Matthew COption exercise / conversion (M)Ordinary Shares4,656USD 31.71USD 147,642SEC filing ↗
2026-06-17Kaye JackSale (S)Ordinary Shares5,295USD 42.57USD 225,408SEC filing ↗
2026-06-17Kaye JackOption exercise / conversion (M)Ordinary Shares5,295USD 31.71USD 167,904SEC filing ↗
2026-06-17Kapusta Matthew CSale (S)Ordinary Shares164,429USD 44.32USD 7,288,062SEC filing ↗
2026-06-17Kapusta Matthew COption exercise / conversion (M)Ordinary Shares62,581USD 19.39USD 1,213,446SEC filing ↗
2026-06-17Balachandran MadhavanSale (S)Ordinary Shares11,685USD 45.06USD 526,485SEC filing ↗
2026-06-17Balachandran MadhavanOption exercise / conversion (M)Ordinary Shares11,685USD 24.97USD 291,807SEC filing ↗
2026-06-15Potts JeannetteSale (S)Ordinary Shares5,237USD 27.67USD 144,908SEC filing ↗
2026-06-15Balachandran MadhavanSale (S)Ordinary Shares10,000USD 27.85USD 278,500SEC filing ↗
2026-06-15Balachandran MadhavanOption exercise / conversion (M)Ordinary Shares10,000USD 8.49USD 84,900SEC filing ↗
2026-06-11Springhorn Jeremy P.Sale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗
2026-06-11POST LEONARD ESale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗
2026-06-11O'Keefe KylieSale (S)Ordinary Shares15,936USD 27.06USD 431,228SEC filing ↗
2026-06-11Meek David D.Sale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗
2026-06-11Kaye JackSale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗
2026-06-11Jacques Rachelle SuzanneSale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗
2026-06-11Gut RobertSale (S)Ordinary Shares2,726USD 27.06USD 73,766SEC filing ↗
2026-06-11Balachandran MadhavanSale (S)Ordinary Shares1,993USD 27.06USD 53,931SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerQURE
CIK0001590560
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history465 transaction lines from 2020-01-07 to 2026-07-02
0 P purchase lines · 294 S sale lines · 171 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.